Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ELEV is expected to report earnings to fall 44.25% to -13 cents per share on November 06
Q3'25
Est.
$-0.13
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.04
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.04
The last earnings report on May 14 showed earnings per share of -23 cents, missing the estimate of -20 cents. With 4.79M shares outstanding, the current market capitalization sits at 21.63M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELEV showed earnings on May 14, 2025. You can read more about the earnings report here.